Pavani Chalasani - The University of Arizona

基本信息

浏览量：15

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 123 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Sequencing of Efficacious Telephone Symptom Management Interventions for Cancer Survivors and Caregivers

Terry Badger,Chris Segrin,Tracy Crane,Pavani Chalasani,Waqas Arslan, Molly Hadeed,Alla Sikorskii

PSYCHO-ONCOLOGY (2024)

引用0浏览0引用

A Sequential Multiple Assignment Randomized Trial of Symptom Management for Cancer Survivors During Treatment and Their Informal Caregivers

Terry Badger,Chris Segrin,Tracy E. Crane,Pavani Chalasani,Waqas Arslan,Mary Hadeed,Charles W. Given,Alla Sikorskii

Supportive Care in Cancer（2024）

引用0浏览0引用

Abstract 782: Correlation Between Collagen Peptides and Physical Features of Fibrosis in Breast Tissue from Women at Increased Risk of Cancer

Denys Rujchanarong,Alison T. Stopeck,Christina Preece, Ren Sun,Pavani Chalasani,Sean Brown, Ji D. Bai, Heather Jensen Smith,Sungyong You,Peggi M. Angel,Patricia Thompson

CANCER RESEARCHno. 6 (2024)

引用0浏览0引用

Predictors of Persistence of Post-Chemotherapy Symptoms among Survivors of Solid Tumor Cancers

Alla Sikorskii,Terry Badger,Chris Segrin,Tracy E. Crane, Nathan Cunicelli,Pavani Chalasani,Waqas Arslan,Charles Given

Quality of Life Researchno. 4 (2024): 1143-1155

引用0浏览0WOS引用

AIPAC-003: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial Testing Eftilagimod Alpha (soluble LAG-3) in Patients with HER2-neg/low Metastatic Breast Cancer Receiving Paclitaxel, Following an Open-Label Dose Optimization

Frederic Forget, Serafin Morales Murillo,Nuhad K. Ibrahim,Bernard Doger de Speille Uribe,Omkar Marathe,Jean-Luc Re Canon,Pavani Chalasani,Konstantinos Papadimitriou,Mafalda Oliveira,Elia Segui,Frederic Triebel

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

Change in Tumor Microenvironment and PD-L1 Expression with Rucaparib Treatment in Triple-Negative Breast Cancer

Ritika Halder, Nitish Bhamidipati,Alexi Kiss,Walaa Aldhahri,Sima Ehsani,Jennifer Margaret Segar,Nova Foster,Pavani Chalasani

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

Supplementary Table S1 from Safety and Tolerability of a Novel Anti-HER2 Antibody–Drug Conjugate (PF-06804103) in Patients with HER2-Expressing Solid Tumors: A Phase 1 Dose-Escalation Study

Funda Meric-Bernstam,Emiliano Calvo,Keun Seok Lee,Victor Moreno,Yeon Hee Park,Sun Young Rha,Pavani Chalasani, Wei Zhong,Li Zhou,Steven Pirie-Shepherd,Abraham C.F. Leung,Giuseppe Curigliano

crossref（2023）

引用0浏览0引用

Figure S2 from Sulindac, a Nonselective NSAID, Reduces Breast Density in Postmenopausal Women with Breast Cancer Treated with Aromatase Inhibitors

Patricia A. Thompson,Chuan Huang,Jie Yang,Betsy C. Wertheim,Denise Roe,Xiaoyue Zhang,Jie Ding,Pavani Chalasani,Christina Preece,Jessica Martinez,H.-H. Sherry Chow,Alison T. Stopeck

crossref（2023）

引用0浏览0引用

Safety and Tolerability of a Novel Anti-HER2 Antibody-Drug Conjugate (PF-06804103) in Patients with HER2-Expressing Solid Tumors: A Phase 1 Dose-Escalation Study

Funda Meric-Bernstam,Emiliano Calvo,Keun Seok Lee,Victor Moreno,Yeon Hee Park,Sun Young Rha,Pavani Chalasani,Wei Zhong,Li Zhou,Steven Pirie-Shepherd,Abraham C. F. Leung,Giuseppe Curigliano

Molecular cancer therapeuticsno. 10 (2023): 1191-1203

引用0浏览0WOS引用

Supplementary Figure S3 from Safety and Tolerability of a Novel Anti-HER2 Antibody–Drug Conjugate (PF-06804103) in Patients with HER2-Expressing Solid Tumors: A Phase 1 Dose-Escalation Study

Funda Meric-Bernstam,Emiliano Calvo,Keun Seok Lee,Victor Moreno,Yeon Hee Park,Sun Young Rha,Pavani Chalasani, Wei Zhong,Li Zhou,Steven Pirie-Shepherd,Abraham C.F. Leung,Giuseppe Curigliano

openalex（2023）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn